Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03311217 Completed - Obesity Clinical Trials

Tribal Health and Resilience in Vulnerable Environments

THRIVE
Start date: June 1, 2016
Phase: N/A
Study type: Interventional

The THRIVE study is a healthy retail intervention that improves the food environments in tribally owned and operated convenience stores in the Chickasaw Nation and Choctaw Nation of Oklahoma.

NCT ID: NCT03307733 Completed - Clinical trials for Maternal Obesity Complicating Pregnancy

Walking in Pregnancy (WiP) - a Social Networking Physical Activity Intervention for Pregnant Obese Women

WiP
Start date: September 1, 2016
Phase: N/A
Study type: Interventional

A physical activity feasibility randomised control trial for pregnant, obese women.

NCT ID: NCT03301519 Completed - Obesity Clinical Trials

Genetics of Beta Cell Failure in Mexican Americans

Start date: July 1, 2001
Phase: N/A
Study type: Observational

This is a family based genotype-phenotype study designed to assess genetic and environmental influences on obesity, insulin resistance and beta cell function in the context of gestational diabetes.

NCT ID: NCT03285074 Completed - Obesity Clinical Trials

The Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With Chronic Kidney Disease

Start date: November 1, 2011
Phase: N/A
Study type: Observational

Unlike the general population, a higher body mass index (BMI) is associated with greater survival among patients with chronic kidney disease (CKD). However, obesity is defined as excess body fat that associated with clearly elevated health risks according to the World Health Organization. In addition, muscle wasting is prevalent among CKD subjects. Thus, we hypothesized that different definition of obesity, based on BMI or body fat percentage, might have different impact on clinical outcomes among CKD population.

NCT ID: NCT03283618 Completed - Obesity Clinical Trials

Implementation of Medical Weight Management by Telemedicine

Start date: November 16, 2015
Phase: N/A
Study type: Interventional

As the prevalence and associated healthcare costs of obesity continue to increase, the need for obesity treatments that contribute to weight loss maintenance are needed. Through the functionality of a smart device, telehealth can provide quality healthcare to individuals of different socioeconomic communities, expand healthcare access, as well as reduce overall healthcare costs. This research program will uncover the effects of a 12-week commercially available telehealth-based weight management program (inHealth Medical Services, Inc.) on body weight, blood pressure, and steps.

NCT ID: NCT03280654 Completed - Clinical trials for Visceral Adiposity Index

Visceral Adiposity Index and Overactive Bladder

Start date: January 1, 2015
Phase: N/A
Study type: Observational [Patient Registry]

In present study, we aimed to investigate the association between visceral adiposity index and overactive bladder symptoms in female patients aged over 18 years.Between January-2015 and July-2017, 151 female patient with overactive bladder symptoms were evaluated in Recep Tayyip Erdogan University Training and Research Hospital Urology Department. Antropometric and laboratory features including serum lipid levels, AST, ALT, fasting glucose levels, and also urodynamic findings were recorded. Visceral adiposity index was calculated according to gender-specific formula. Participants were divided into two groups according to 7,55 cut-off level for visceral adiposity index levels. Statistical significance were discussed between two groups.

NCT ID: NCT03279432 Completed - Obesity Clinical Trials

Vitamin D-related Genes and Metabolic Disorders

Start date: August 18, 2004
Phase: N/A
Study type: Observational

The link between metabolic disturbances and vitamin D receptor (VDR) and MEGALIN (or LRP2) gene polymorphisms remains unclear, particularly among African-American adults. The associations of single nucleotide polymorphisms (SNPs) for VDR [rs1544410(BsmI:G/A), rs7975232(ApaI:A/C), rs731236(TaqI:G/A)] and MEGALIN [rs3755166:G/A,rs2075252:C/T, rs2228171:C/T] genes with incident and prevalent metabolic disturbances, including obesity, central obesity and metabolic syndrome (MetS) were evaluated. From 1,024 African-Americans participating in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS, Baltimore, MD, 2004-2013) study, 539 subjects were selected who had complete genetic data as well as covariates selected for metabolic outcomes at two consecutive examinations (visits 1 and 2) with a mean follow-up time of 4.64±0.93y. Haplotype (HAP) analyses generated polymorphism groups that were linked to incident and prevalent metabolic disturbances.

NCT ID: NCT03278951 Completed - Obesity Clinical Trials

Video Conferencing and In-person Health Coaching on Weight Loss, Physical Activity, and Metabolic Control

Start date: January 30, 2016
Phase: N/A
Study type: Interventional

The purpose of this study was to determine how 12 weeks of health coaching with individualized feedback and education in combination with mobile health devices (a digital wireless body weight scale and wireless activity tracker) influences body weight, waist circumference, physical activity levels, and select blood-borne markers of health (fasting blood glucose, hemoglobin A1c, and insulin). The individualized health coaching, education, and feedback was delivered by either video conferencing or direct, in-person consultation. All education materials including (i.e. video modules, exercise manuals, nutrition manuals) were designed and compiled by a team of health professionals from (inHealth Medical Services, Inc.). These materials focused on incorporating behavioral principles of self-monitoring, exercise, nutrition, goal setting, and behavior modification. Each participant was randomly assigned into one of two intervention groups (a video conferencing or in-person group) or a control group.

NCT ID: NCT03277963 Completed - Obesity Clinical Trials

Perception of Pain During Obstructive Sleep Apnea Syndrome in Obese Patient

Start date: February 4, 2010
Phase: N/A
Study type: Interventional

Obstructive sleep apnea syndrome (SAOS), very commonly associated with obesity, induces major disturbances in sleep architecture. The hypotheses in this work are twofold: on the one hand, the SAOS could generate pain perception disorders in a population already affected by the mechanical weight constraints, generating potentially painful complications, and on the other hand, the improvement of sleep provided by continuous positive airway pressure (PPC) ventilation could "normalize" the pain perception thresholds. It was shown an early rebound effect after treatment on increasing pain threshold in the healthy subject. We want to check it among obese patients with OSA in early and mid-term.

NCT ID: NCT03272074 Completed - Obesity Clinical Trials

Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes

Start date: September 11, 2015
Phase: N/A
Study type: Interventional

The intent of this study is to examine the extent to which daily incorporation of egg into a diet improves glycemic control, insulin sensitivity, lipid profiles, and body composition in overweight and obese adults with pre- and type II-diabetes. The hypothesis of this study is that the daily incorporation of one large egg into a diet for 12 weeks will exert positive effects on factors associated with glycemic control and insulin sensitivity in overweight and obese adults with pre- and type II-diabetes through improvements in body weight, body composition, and lipid metabolism.